Showing results (5081-5090 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|December 29, 2015
Manufacturing of [(14)C]-Labeled Drug Substance and Drug Product Utilized in Clinical Research: A Case Study of Omecamtiv MecarbilScott W Roberts, Jeroen M Bezemer, Michael T Kennedy, et al.Current Pharmaceutical Design|January 29, 2016
The Cholinergic System: An Emerging Drug Target for SchizophreniaAndrew Gibbons, Brian DeanCurrent Pharmaceutical Design|January 29, 2016
Targeting the Cholinergic System for Neuroprotection and/or Enhancement of Functional Recovery Following NeurotraumaKathleen B G Huber, Victor V Uteshev, James R PaulyCurrent Pharmaceutical Design|January 29, 2016
Serotonergic Drugs: Agonists/Antagonists at Specific Serotonergic Subreceptors for the Treatment of Cognitive, Depressant and Psychotic Symptoms in Alzheimer's DiseaseFelix-Martin Werner, Rafael CovenasCurrent Pharmaceutical Design|January 29, 2016
Obstacles and Opportunities for Cholinergic Drug Development in the Treatment of Cognitive DisordersRachel A Schroeder, Lynn Wecker, Rex M PhilpotCurrent Pharmaceutical Design|January 29, 2016
Selected Engineering and Physicochemical Aspects of Systemic Drug Delivery by InhalationTomasz R SosnowskiCurrent Pharmaceutical Design|February 3, 2016
Αlpha-2 Adrenergic and Opioids Receptors Participation in Mice Gastroprotection of Abelmoschus esculentus LectinKátia A Ribeiro, Hellíada V Chaves, Samuel Mateus Pereira Filho, et al.Current Pharmaceutical Design|January 12, 2016
Historical Hallmarks of Anticoagulation and Antiplatelet AgentsGregory Tsoucalas, Jacques Chevallier, Marianna Karamanou, et al.Current Pharmaceutical Design|January 14, 2016
Mycobacterium tuberculosis-Secreted Tyrosine Phosphatases as Targets Against Tuberculosis: Exploring Natural Sources in Searching for New DrugsAlessandra Mascarello, Louise Domeneghini Chiaradia-Delatorre, Mattia Mori, et al.Pageof 1,008